Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1984 Sep;20(3):409–412. doi: 10.1128/jcm.20.3.409-412.1984

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.

R N Jones, C Thornsberry, A L Barry, L Ayers, S Brown, J Daniel, P C Fuchs, T L Gavan, E H Gerlach, J M Matsen, et al.
PMCID: PMC271340  PMID: 6490826

Abstract

HR810 is a new, very broad-spectrum cephalosporin with significant activity against members of the family Enterobacteriaceae, pseudomonads, gram-positive cocci, and anaerobes that is generally greater than the third-generation cephalosporins (99.6% of 4,128 clinical facultative enteric isolates were inhibited by less than or equal to 8.0 micrograms of HR810 per ml). Tests and statistical methods to establish in vitro antimicrobial susceptibility test criteria favor tentative breakpoints of greater than or equal to 18 mm (less than or equal to 8.0 micrograms/ml) as susceptible and less than or equal to 14 mm (greater than or equal to 32 micrograms/ml) as resistant. This provides a 93.7 to 98.3% absolute interpretive accuracy. Several preliminary ranges for zone sizes obtained with quality control organisms are proposed for the 30-micrograms HR810 disk diffusion test used during the clinical trials.

Full text

PDF
409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Gavan T. L., Jones R. N. Quality control parameters for susceptibility tests with 30-micrograms netilmicin disks. J Clin Microbiol. 1983 Nov;18(5):1051–1054. doi: 10.1128/jcm.18.5.1051-1054.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Bauernfeind A. Susceptibility of gram-positive aerobic cocci to the new cephalosporin HR 810. Eur J Clin Microbiol. 1983 Aug;2(4):354–355. doi: 10.1007/BF02019468. [DOI] [PubMed] [Google Scholar]
  4. Cullmann W., Opferkuch W., Stieglitz M. Relation between beta-lactamase production and antimicrobial activity: comparison of the new compound HR 810 with cefotaxime. Eur J Clin Microbiol. 1983 Aug;2(4):350–352. doi: 10.1007/BF02019466. [DOI] [PubMed] [Google Scholar]
  5. Gavan T. L., Jones R. N., Barry A. L., Fuchs P. C., Gerlach E. H., Matsen J. M., Reller L. B., Thornsberry C., Thrupp L. D. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol. 1981 Jul;14(1):67–72. doi: 10.1128/jcm.14.1.67-72.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jones R. N., Barry A. L. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics. Rev Infect Dis. 1983 Mar-Apr;5 (Suppl 1):S108–S126. doi: 10.1093/clinids/5.supplement_1.s108. [DOI] [PubMed] [Google Scholar]
  7. Jones R. N., Thornsberry C., Barry A. L. In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin. Antimicrob Agents Chemother. 1984 Jun;25(6):710–718. doi: 10.1128/aac.25.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jones R. N., Thornsberry C. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity. Rev Infect Dis. 1982 Sep-Oct;4 (Suppl):S300–S315. doi: 10.1093/clinids/4.supplement_2.s300. [DOI] [PubMed] [Google Scholar]
  9. Machka K., Braveny I. In vitro activity of HR 810, a new broad-spectrum cephalosporin. Eur J Clin Microbiol. 1983 Aug;2(4):345–349. doi: 10.1007/BF02019465. [DOI] [PubMed] [Google Scholar]
  10. Rotimi V. O., Turk D. C. Transferable multiple antibiotic resistance in Haemophilus influenzae. J Antimicrob Chemother. 1981 Sep;8(3):187–192. doi: 10.1093/jac/8.3.187. [DOI] [PubMed] [Google Scholar]
  11. Seibert G., Klesel N., Limbert M., Schrinner E., Seeger K., Winkler I., Lattrell R., Blumbach J., Dürckheimer W., Fleischmann K. HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum. Arzneimittelforschung. 1983;33(8):1084–1086. doi: 10.1002/chin.198350201. [DOI] [PubMed] [Google Scholar]
  12. Seibert G., Limbert M., Winkler I., Dick T. The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides. Infection. 1983 Sep-Oct;11(5):275–279. doi: 10.1007/BF01641262. [DOI] [PubMed] [Google Scholar]
  13. Tolxdorff-Neutzling R. M., Wiedemann B. HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase. Eur J Clin Microbiol. 1983 Aug;2(4):352–354. doi: 10.1007/BF02019467. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES